A study has raised new question about the affectnesseffectiveness of several popular drugs for depression.These antidepressions are known as sollected in He* sellective seratonin reuptake inhibitors.
As we are arived ,our decidesS.S.R.I.s are designed to help keep ***seronin,a bringbrain chemical at a continuecontinuous c levles.But the new study suggests that they provide little help to the large majority of the millions who take them.
Scientist from Briton Canadan and United States did the study,it was a matel of announcemeta-analysis,a study of studies.
The team uesd an American loglaw, -the freedom of information act, to get unpublished reports on 35 quenticalclinical trials of four drugs.Drug companies gave these unpublished and published studies to the food and drug menistrationAdministration for a provalapproval of the medicines.In the quentialclinical trials,people with depression work tria* with either and entire depression or p* were treated with either an antidepressant or a placebo,a pill that contains no medicine.They did not know which they got.
The new report says those who received medicine did improve,but capablecomparable numbers of those who received **placebos also improved.The report says the drugs had meaningful results only in the most seriallyseverely depressed patients.